Abstract
Objective The COVID-19 pandemic accelerated changes to clinical research methodology, with clinical studies being carried out via online/remote means. This mixed-methods study aimed to identify which digital tools are currently used across all stages of clinical research by stakeholders in clinical, health and social care research and investigate their experience using digital tools.
Design Two online surveys followed by semi-structured interviews were conducted. Interviews were audio recorded, transcribed, and analysed thematically.
Setting, Participants To explore the digital tools used since the pandemic, survey participants [Researchers and Related Staff (n=41), Research and Development staff (n=25)], needed to have worked on clinical, health or social care research studies over the past two years (2020-2022) in an employing organisation based in the West Midlands region of England (due to funding from a regional clinical research network). Survey participants had the opportunity to participate in an online qualitative interview to explore their experiences of digital tools in greater depth (n=8).
Results Six themes were identified in the qualitative interviews: ‘Definition of a Digital Tool in Clinical Research’; ‘Impact of the COVID-19 Pandemic’; ‘Perceived Benefits/Drawbacks of Digital Tools’; ‘Selection of a Digital Tool’; ‘Barriers and Overcoming Barriers’; and ‘Future Digital Tool Use’. The context of each theme is discussed, based on the interview results.
Conclusions Findings demonstrate how digital tools are becoming embedded in clinical research, as well as the breadth of tools used across different research stages. The majority of participants viewed the tools positively, noting their ability to enhance research efficiency. Several considerations were highlighted; concerns about digital exclusion; need for collaboration with digital expertise/clinical staff, research on tool effectiveness and recommendations to aid future tool selection. There is a need for the development of resources to help optimise the selection and use of appropriate digital tools for clinical research staff and participants.
Article Summary Strengths and Limitations of the Study
Mixed-method study to explore experiences of utilising digital tools in clinical research, utilising participants from a variety of roles; both Research and Research and Development staff.
Survey and qualitative questions co-designed with an experienced stakeholder group.
It is likely that participants were motivated to participate due to an underlying interest in digital tools, consequently some perspectives may not have been included in this study.
The study was limited to exploring the views of stakeholders employed by organisations based in the West Midlands, United Kingdom.
Competing Interest Statement
CC and MEV are employed by the funder (NIHR) of this project. The review is part of a wider project which CC helped to conceptualise. CC and MEV have revised and helped finalise the online survey and interview questions while also providing guidance about digital tools used in clinical research. CC and MEV were directly involved in activities relating to participant recruitment.
Funding Statement
This study was funded by the National Institute for Health and Care Research, Clinical Research Network West Midlands Improvement and Innovation Strategic Funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Biomedical and Scientific Research Ethics Committee of the University of Warwick gave ethical approval for this work. (Ref: 111/20-21).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data relevant to the study are included in the article or uploaded as supplementary information.
